Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.10.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Sales $ 250,227 $ 292,508
COST OF SALES (186,068) (191,320)
GROSS PROFIT 64,159 101,188
EXPENSES:    
Depreciation (Note 9) 19,392 45,377
Amortization of patent rights (Note 16) 3,666  
Foreign currency transaction (gain) loss (46,093) 55,007
Selling, general and administration 2,125,896 1,919,789
TOTAL OPERATING EXPENSES 2,102,861 2,020,173
LOSS FROM OPERATIONS (2,038,702) (1,918,985)
Accretion (Note 14) (154,428) (103,034)
Other expense-interest (Note 14) (148,887) (538,430)
Change in fair value of derivative liabilities (Note 14) 188,543 (239,802)
LOSS BEFORE INCOME TAXES (2,153,474) (2,800,251)
Income taxes (Note 10) 0 0
NET LOSS (2,153,474) (2,800,251)
Foreign exchange translation adjustment for the year (1,673) 24,734
COMPREHENSIVE LOSS $ (2,155,147) $ (2,775,517)
Loss per share - basic and diluted (in dollars per share) $ (0.02) $ (0.05)
Weighted average number of common shares outstanding during the year (in shares) 94,446,113 57,700,128